on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Proposes Steady Dividend for 2025
Sartorius Stedim Biotech S.A.'s Board of Directors has resolved to propose a dividend of 0.69 euros per share for the fiscal year 2025, maintaining the same dividend level as 2024. The decision, made on February 4, 2026, will be presented to the Annual Shareholders' Meeting scheduled for March 24, 2026. If approved, this will result in a total distributed profit of 67.1 million euros, with shareholders set to receive their dividends starting April 2, 2026.
The Board also plans to submit the 2025 results at the shareholders' meeting, which have previously been released in a preliminary format. The company's financials and strategic decisions continue to be influenced by various uncertainties and potential risks, as noted in their media release.
Founded in Aubagne, France, Sartorius Stedim Biotech is a significant entity in the biopharmaceutical sector, offering innovative solutions for biotech medication production. The company achieved approximately 3 billion euros in sales revenue for 2025.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news